Humana (HUM +0.8%)
has filed a 610-page complaint in a Philadelphia federal court accusing
more than a dozen generic drug makers, including Teva Pharmaceutical
Industries (TEVA -2.5%),
of conspiring to maintain high prices on 124 generic medicines. The
suit claims that Teva “spearheaded” the scheme although it was cog in
much larger conspiracy to inflate drug prices.
The supposed peak of collusive activity was the period from July 2013 through January 2015.
Humana also filed a 273-page complaint in a Philadelphia court in August 2018 against generic drug firms so it is unclear how the two differ.
The latest case is: Humana Inc. v. Actavis Elizabeth LLC, 2:19-cv-4862, U.S. District Court, Eastern District of Pennsylvania.
https://seekingalpha.com/news/3507021-humana-sues-generic-drug-makers-alleged-price-fixing
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.